Benefits of SGLT2 Inhibitor: Preventing Heart Failure and Beyond
نویسندگان
چکیده
منابع مشابه
Diastolic heart failure in hypertension: possible preventive benefits of nebivolol beyond lowering blood pressure.
ABSTRACT Arterial hypertension is one of the most prevalent cardiovascular diseases and one of the most important causes of heart failure with low or preserved ejection fraction. Although many drugs are highly effective in lowering blood pressure, the optimal treatment for preventing progression to heart failure is still uncertain. Beta-blockers, a class of drugs with well-established indicatio...
متن کاملLooking beyond haemodynamics in chronic heart failure.
We read with great interest the excellent review article on drug therapy in chronic heart failure (CHF) by McKenzie and Cowley. The authors discuss the haemodynamic, neurohormonal, and sympathetic nervous system mechanisms contributing to heart failure, but maintain a cardiocentric view in explaining how these three mechanisms together lead to the deterioration of the failing heart and its haem...
متن کاملChronic heart failure beyond city limits.
INTRODUCTION Chronic heart failure (CHF) develops in frail elderly individuals who have suffered an acute or sustained insult to the structural efficiency of the heart due to the presence of underlying heart disease and/or hypertension. It is also more common in individuals with disproportionately high levels of cardiac disease or its risk factors, for example lower socioeconomic status. As suc...
متن کاملRisks and benefits of weight loss in heart failure.
Obesity adversely affects many cardiovascular disease (CVD) risk factors and increases the risk of most CVD, including heart failure (HF). HF is markedly increased in the setting of obesity. However, obese patients with HF have a better prognosis than lean patients with HF, which has been termed the obesity paradox. Therefore, the role of weight loss, which generally improves ventricular struct...
متن کاملRisks and Benefits of Risk Prediction in Acute Heart Failure.
SEE PAGE 737 D espite the remarkable advances in the treatment of acute and chronic heart failure (HF), prognosis assessment remains an ongoing challenge. Multiple cardiovascular diseases lead to the development of HF. Treatment options for these diseases are evolving, which leads to greater numbers of patients reaching the final state of HF at a later age with a greater comorbidity burden. The...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean Circulation Journal
سال: 2019
ISSN: 1738-5520,1738-5555
DOI: 10.4070/kcj.2019.0287